NCT00016016View on ClinicalTrials.gov

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

November 30, 2006

Conditions
Recurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaUntreated Adult Acute Lymphoblastic LeukemiaUntreated Adult Acute Myeloid Leukemia
Interventions
DRUG

cytarabine

Given IV

DRUG

mitoxantrone hydrochloride

Given IV

DRUG

alvocidib

Given IV

OTHER

pharmacological study

Correlative studies

OTHER

laboratory procedure

Correlative studies

Trial Locations (1)

21287-8936

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00016016 - Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia | Biotech Hunter | Biotech Hunter